Cytokines and liver diseases - PubMed (original) (raw)
Review
Cytokines and liver diseases
H Tilg. Can J Gastroenterol. 2001 Oct.
Abstract
Cytokines are pleiotropic peptides produced by virtually every nucleated cell in the body. In most tissues, including the liver, constitutive production of cytokines is absent or minimal. There is increasing evidence that several cytokines mediate hepatic inflammation, apoptosis and necrosis of liver cells, cholestasis and fibrosis. Interestingly, the same mediators also mediate the regeneration of liver tissue after injury. Among the various cytokines, the proinflammatory cytokine tumour necrosis factor-alpha (TNF-a) has emerged as a key factor in various aspects of liver disease, such as cachexia and/or cholestasis. Thus, antagonism of TNF-a and other injury-related cytokines in liver diseases merits evaluation as a treatment of these diseases. However, because the same cytokines are also necessary for the regeneration of the tissue after the liver has been injured, inhibition of these mediators might impair hepatic recovery. The near future will bring the exiting clinical challenge of testing new anticytokine strategies in various liver diseases.
Similar articles
- Cytokine regulation of liver injury and repair.
Diehl AM. Diehl AM. Immunol Rev. 2000 Apr;174:160-71. doi: 10.1034/j.1600-0528.2002.017411.x. Immunol Rev. 2000. PMID: 10807515 Review. - [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
Schaff Z, Nagy P. Schaff Z, et al. Orv Hetil. 2004 Aug 29;145(35):1787-93. Orv Hetil. 2004. PMID: 15493221 Review. Hungarian. - Prometheus' challenge: molecular, cellular and systemic aspects of liver regeneration.
Pahlavan PS, Feldmann RE Jr, Zavos C, Kountouras J. Pahlavan PS, et al. J Surg Res. 2006 Aug;134(2):238-51. doi: 10.1016/j.jss.2005.12.011. Epub 2006 Feb 3. J Surg Res. 2006. PMID: 16458925 Review. - Upregulated promitogenic signaling via cytokines and growth factors: potential mechanism of robust liver tissue repair in calorie-restricted rats upon toxic challenge.
Apte UM, Limaye PB, Ramaiah SK, Vaidya VS, Bucci TJ, Warbritton A, Mehendale HM. Apte UM, et al. Toxicol Sci. 2002 Oct;69(2):448-59. doi: 10.1093/toxsci/69.2.448. Toxicol Sci. 2002. PMID: 12377994
Cited by
- Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study.
Kronborg TM, Ytting H, Hobolth L, Møller S, Kimer N. Kronborg TM, et al. Front Med (Lausanne). 2021 Sep 23;8:718896. doi: 10.3389/fmed.2021.718896. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34631742 Free PMC article. - Sarcopenia in a mice model of chronic liver disease: role of the ubiquitin-proteasome system and oxidative stress.
Campos F, Abrigo J, Aguirre F, Garcés B, Arrese M, Karpen S, Cabrera D, Andía ME, Simon F, Cabello-Verrugio C. Campos F, et al. Pflugers Arch. 2018 Oct;470(10):1503-1519. doi: 10.1007/s00424-018-2167-3. Epub 2018 Jun 20. Pflugers Arch. 2018. PMID: 29926227 - The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology.
Berthold-Losleben M, Himmerich H. Berthold-Losleben M, et al. Curr Neuropharmacol. 2008 Sep;6(3):193-202. doi: 10.2174/157015908785777238. Curr Neuropharmacol. 2008. PMID: 19506720 Free PMC article. - Hepatic Overlap Syndrome Improved With Infliximab.
Hilzenrat N, Lamoureux E, Cohen A, Baron M. Hilzenrat N, et al. Gastroenterol Hepatol (N Y). 2006 Feb;2(2):88-90. Gastroenterol Hepatol (N Y). 2006. PMID: 28286433 Free PMC article. No abstract available. - A Three Stage Integrative Pathway Search (TIPS) framework to identify toxicity relevant genes and pathways.
Li Z, Srivastava S, Mittal S, Yang X, Sheng L, Chan C. Li Z, et al. BMC Bioinformatics. 2007 Jun 14;8:202. doi: 10.1186/1471-2105-8-202. BMC Bioinformatics. 2007. PMID: 17570844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical